Park National Corp OH Has $11.09 Million Stock Holdings in CVS Health Corporation $CVS

Park National Corp OH reduced its stake in CVS Health Corporation (NYSE:CVS) by 19.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 139,677 shares of the pharmacy operator’s stock after selling 32,928 shares during the period. Park National Corp OH’s holdings in CVS Health were worth $11,085,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. SOA Wealth Advisors LLC. lifted its stake in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 131 shares during the last quarter. Alteri Wealth LLC grew its stake in CVS Health by 3.2% in the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 131 shares during the last quarter. Holistic Financial Partners raised its holdings in CVS Health by 4.1% in the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after acquiring an additional 133 shares during the period. CYBER HORNET ETFs LLC lifted its position in CVS Health by 4.1% during the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 134 shares during the last quarter. Finally, Fayez Sarofim & Co boosted its holdings in shares of CVS Health by 2.1% during the third quarter. Fayez Sarofim & Co now owns 6,913 shares of the pharmacy operator’s stock worth $521,000 after acquiring an additional 140 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

CVS Health stock opened at $71.86 on Friday. The firm has a market cap of $91.41 billion, a PE ratio of 52.07, a price-to-earnings-growth ratio of 0.76 and a beta of 0.49. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock’s fifty day moving average price is $77.66 and its two-hundred day moving average price is $77.79. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the prior year, the company posted $1.19 EPS. The company’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.7%. The ex-dividend date of this dividend is Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

Wall Street Analyst Weigh In

Several research firms have recently commented on CVS. Bank of America lowered their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research note on Tuesday, January 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Barclays increased their price objective on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Leerink Partners reissued an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research report on Thursday, March 5th. Finally, JPMorgan Chase & Co. upped their price target on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $95.05.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Board-approved quarterly dividend of $0.665/share (payable May 4, 2026), supporting income investors and signaling confidence in cash flow. CVS Health declares quarterly dividend
• Positive Sentiment: CVS Health Foundation commits $2.24M to a Health Zone in Charlotte’s Historic West End — positive for brand, community relations and ESG positioning. CVS Health Foundation Invests $2.24 Million
• Neutral Sentiment: Company executive discussed CVS/Aetna AI policy and quality trade-offs — indicates management focus on AI governance but no immediate financial impact disclosed. CVS Health/Aetna executive discusses company AI policy
• Neutral Sentiment: CVS is getting increased retail investor attention; Zacks/Yahoo pieces note the stock is trending and review fundamentals — may boost trading volume but not a directional fundamental driver. CVS trending stock: Zacks
• Neutral Sentiment: CVS executive Dana Prommel Strauss joins Bioliberty board — adds industry expertise and partnership potential, limited short-term stock impact. Bioliberty Raises $10.2 million
• Neutral Sentiment: Company confirms it will remain at the Somerset distribution site despite a potential sale — operational stability for the supply chain. CVS to remain at Somerset distribution
• Negative Sentiment: New Tennessee legislation targeting PBMs (the “Fair Rx” proposals) could force changes to PBM practices and, per reports, threaten closure of 100+ CVS stores in the state — raises regulatory and revenue risk in a meaningful local market. TN bill could threaten closure of 100+ CVS stores
• Negative Sentiment: Tennessee House finance committee has moved the Fair Rx Act forward amid public dispute with CVS — legislative momentum increases near-term political/regulatory risk for the PBM model. TN House finance committee moves Fair Rx Act
• Negative Sentiment: Class-action racketeering lawsuit filed by Bernstein Litowitz against CaremarkPCS and CVS alleges PBM fraud—adds legal exposure and potential reputational/financial risk. BLB&G files racketeering class action

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.